Publication at First Faculty of Medicine |
2014
Abstract
Sodium hyaluronate is a new preparation used for the treatment of UC and the clinical experiences are minimal. In relation to prescribing and clinical practice, it is necessary to point out that it is not a cure, but the CHC medical device for use as adjunctive therapy of intestinal inflammation.
Its actual efficacy and subsequent positions in the therapeutic armamentarium UC will require a randomized placebo-controlled trials. However, the fact that the substance is the human body's own, and considering the very good tolerability of the preparation, can already be considered its use in patients with proctitis or left-sided UC who do not respond adequately to conventional treatment of oral or rectal administration.